digital health funding
Investors have showered the New York company with $876 million to date.
The company said that its platform is tracking more than 325 million patients' healthcare encounters.
The round was led by Insight Partners Spark Capital, Concord Health Partners and HWVP with participation from KKR, Rivas Capital and Sigmas Group.
The startup's platform now covers more than 20 million lives and is available worldwide.
The Palo Alto startup said that 2020 was its strongest year to date.
This Series C comes less than a year after the startup closed its $200 million Series B in 2020.
The company currently has 11 locations delivering virtual-supported care, but now plans to open "several" more in the first half of 2021.
The company's technology looks to reduce the burden on pathologists reviewing digital slides, while also serving as a safety net to reduce errors.
Also: Valo Health closes $300 million for machine learning drug discovery; Blue Note Therapeutics supports its in-development prescription DTx with $26.25 million.
The company is initially targeting the large employer market with its app-connected biometric monitoring tools.